Literature DB >> 33426365

Porphyrinoid Drug Conjugates.

Jonathan F Arambula1,2, Jonathan L Sessler1.   

Abstract

Drawing inspiration from nature today remains a time-honored means of discovering the therapies of tomorrow. Porphyrins, the so-called "pigments of life" have played a key role in this effort due to their diverse and unique properties. They have seen use in a number of medically relevant applications, including the development of so-called drug conjugates wherein functionalization with other entities is used to improve efficacy while minimizing dose limiting side effects. In this Perspective, we highlight opportunities associated with newer, completely synthetic analogs of porphyrins, commonly referred to as porphyrinoids, as the basis for preparing drug conjugates. Many of the resulting systems show improved medicinal or site-localizing properties. As befits a Perspective of this type, our efforts to develop cancer-targeting, platinum-containing conjugates based on texaphyrins (a class of so-called "expanded porphyrins") will receive particular emphasis; however, the promise inherent in this readily generalizable approach will also be illustrated briefly using two other common porphyrin analogs, namely the corroles (a "contracted porphyrin") and porphycene (an "isomeric porphyrin").

Entities:  

Year:  2020        PMID: 33426365      PMCID: PMC7793029          DOI: 10.1016/j.chempr.2020.06.019

Source DB:  PubMed          Journal:  Chem            Impact factor:   22.804


  53 in total

1.  Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates.

Authors:  Federico M Lauro; Patrizia Pretto; Loredana Covolo; Giulio Jori; Giulio Bertoloni
Journal:  Photochem Photobiol Sci       Date:  2002-07       Impact factor: 3.982

Review 2.  Texaphyrins: tumor localizing redox active expanded porphyrins.

Authors:  Jonathan F Arambula; Christian Preihs; Derric Borthwick; Darren Magda; Jonathan L Sessler
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

3.  Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugate.

Authors:  Jonathan F Arambula; Jonathan L Sessler; Zahid H Siddik
Journal:  Bioorg Med Chem Lett       Date:  2011-01-26       Impact factor: 2.823

Review 4.  Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.

Authors:  Oktay Tacar; Pornsak Sriamornsak; Crispin R Dass
Journal:  J Pharm Pharmacol       Date:  2012-08-02       Impact factor: 3.765

5.  Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points.

Authors:  Minesh P Mehta; William R Shapiro; Michael J Glantz; Roy A Patchell; Michael A Weitzner; Christina A Meyers; Christopher J Schultz; Wilson H Roa; Mark Leibenhaut; Judith Ford; Walter Curran; See Phan; Jennifer A Smith; Richard A Miller; Markus F Renschler
Journal:  J Clin Oncol       Date:  2002-08-15       Impact factor: 44.544

Review 6.  Cisplatin: mode of cytotoxic action and molecular basis of resistance.

Authors:  Zahid H Siddik
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

7.  Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator.

Authors:  Gregory Thiabaud; Rebecca McCall; Guangan He; Jonathan F Arambula; Zahid H Siddik; Jonathan L Sessler
Journal:  Angew Chem Int Ed Engl       Date:  2016-07-05       Impact factor: 15.336

8.  The First Direct Synthesis of Corroles from Pyrrole.

Authors:  Zeev Gross; Nitsa Galili; Irena Saltsman
Journal:  Angew Chem Int Ed Engl       Date:  1999-05-17       Impact factor: 15.336

9.  Toward a chemical marker for inflammatory disease: a fluorescent probe for membrane-localized thioredoxin.

Authors:  Min Hee Lee; Hyun Mi Jeon; Ji Hye Han; Nayoung Park; Chulhun Kang; Jonathan L Sessler; Jong Seung Kim
Journal:  J Am Chem Soc       Date:  2014-05-28       Impact factor: 15.419

10.  Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tumor cells.

Authors:  Michelle Bhatt; Cristina Ivan; Xiaolei Xie; Zahid H Siddik
Journal:  Oncotarget       Date:  2017-02-14
View more
  2 in total

1.  Controlled assembly of a bicyclic porphyrinoid and its 3-dimensional boron difluoride arrays.

Authors:  Weinan Zhou; Tridib Sarma; Liu Yang; Chuanhu Lei; Jonathan L Sessler
Journal:  Chem Sci       Date:  2022-05-26       Impact factor: 9.969

2.  Versatile Synthesis of Multivalent Porphyrin-Peptide Conjugates by Direct Porphyrin Construction on Resin.

Authors:  Yue Wu; Ho-Fai Chau; Yik-Hoi Yeung; Waygen Thor; Hei-Yui Kai; Wai-Lun Chan; Ka-Leung Wong
Journal:  Angew Chem Int Ed Engl       Date:  2022-07-11       Impact factor: 16.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.